Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
Bucking the Trend, Top Hedge Fund Makes Plans for a Second SPAC
Stephen Taub
January 25, 2024
Hedge Funds Eye Three Biopharma IPOs
Stephen Taub
January 24, 2024
Greenlight Establishes a New Top-Five Position
Stephen Taub
January 22, 2024
Premium
Macro Funds End 2023 With Mediocre Results
Stephen Taub
January 22, 2024
Premium
How a Hedge Fund Headed by a Former SAC Tech Investor Stands Apart From TMT Rivals
Stephen Taub
January 18, 2024
Premium
A Volatile Hedge Fund Turned It Around Last Year
Stephen Taub
January 17, 2024
Premium
Tiger Funds Play the Long Game
Stephen Taub
January 16, 2024
Premium
Life Sciences Hedge Funds Make a Stunning Recovery
Stephen Taub
January 11, 2024
Premium
Viking Stands Apart From Other Tiger Cubs
Stephen Taub
January 10, 2024
Premium
Jamie Sterne’s Skye Global Soars Again
Stephen Taub
January 9, 2024
Premium
How Dan Loeb’s Hedge Fund Turned It Around in the Fourth Quarter
Stephen Taub
January 8, 2024
Premium
AQR Tops Multistrategy Funds in 2023
Stephen Taub
January 5, 2024
Premium
Tepper’s Two-Year Feat
Stephen Taub
January 4, 2024
Premium
Hedge Fund Faves Beat the Market in the Fourth Quarter
Stephen Taub
January 3, 2024
Premium
Greenlight Finishes the Year on a Losing Note
Stephen Taub
January 2, 2024
Premium
Hedge Funds Seek Health Care Deals
Stephen Taub
December 21, 2023
Premium
Why Seligman Thinks Tesla Is Still an Attractive Short
Stephen Taub
December 20, 2023
Premium
Another Quiet Year for VC Deals
Stephen Taub
December 19, 2023
More Articles